Brief: NKGen Biotech Enters Seventh Amendment To Forward Purchase Agreement Dated Sept 22, 2023
02/01/2025 22:36
Jan 2 (Reuters) - Nkgen Biotech Inc NKGN.O :
* NKGEN BIOTECH INC - ENTERS SEVENTH AMENDMENT TO FORWARD
PURCHASE
AGREEMENT DATED SEPT 22, 2023
* NKGEN BIOTECH INC: UNDER AMENDMENT, CO AND SELLER AGREED
TO
EXTEND VALUATION DATE TO DEC 31, 2025
Source text: ID:n0001213900-25-000418
Further company coverage: NKGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nkgen Biotech
See all newsBrief: Nkgen Biotech Expands Clinical Trial Site Network For Alzheimer’S Disease Program Across US
Brief: NKgen Biotech And Hekabio Enter Into Strategic Partnership
Brief: Nkgen Biotech Announces International And U.S. Expansion Of Phase 1/2A Troculeucel Alzheimer’S Trial
Brief: Nkgen Biotech Announces Administration Of First Dose Of Troculeucel To Stroke Patient Under FDA-Cleared Compassionate Use Program
Brief: NKGen Biotech Announces Administration Of First Dose Of Troculeucel To Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program